# Alkem Laboratories Ltd (ALKEM)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹5404.5
Day Change: -1.76%
52W High: ₹5933.5
52W Low: ₹4716.2
Market Cap: ₹65,211 Cr

## Valuation
P/E: 27.54
P/B: 4.89
EPS: ₹198.04
Book Value: ₹1116.26
Dividend Yield: 0.93%

## Returns
1Y Return: -3.77%

## Profitability
ROE: 0%
ROCE: 19.72%
Debt/Equity: 0.17
Revenue Growth: 10.7%
Profit Growth: 1.6%
EBITDA Margin: 19.89%
Operating Margin: 19.61%

## About
Alkem Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Alkem Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Announcement: Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- BSE Filing: Announcement under Regulation 30 (LODR)-Press Release / Media Release

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.754Z
Price History Updated: 2026-05-17T21:24:02.188Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:24:02.188Z
Quant Updated: 2026-05-17T21:24:02.188Z
Sentiment Updated: 2026-05-17T21:24:02.188Z
Financials Status: current
Financials Updated: 2026-05-18T04:30:27.938Z
Financials Last Attempt: 2026-05-18T04:30:27.938Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹3113 Cr
Operating Profit: ₹413 Cr (OPM 13%)
Net Profit: ₹435 Cr
Tax: ₹430 Cr

## Annual P&L History
Mar 2015: Rev ₹3113Cr | PAT ₹435Cr | OPM 13%
Mar 2016: Rev ₹3674Cr | PAT ₹392Cr | OPM 12%
Mar 2017: Rev ₹4905Cr | PAT ₹752Cr | OPM 18%

## Balance Sheet (Mar 2015)
Total Assets: ₹4311 Cr
Total Liabilities: ₹4311 Cr
Borrowings: ₹1128 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Basudeo Narian Singh, Executive Chairman
- Sandeep Derjit Singh, MD & Executive Director
- Mritunjay Kumar Singh, Executive Director
- Srinivas  Singh, Executive Director
- Madhurima  Singh, Executive Director

---
Source: rupiya.io/stocks/alkem
Disclaimer: For research and education only. Not investment advice.